Disease Registry Software Market Report 2026

The disease registry software market size has grown rapidly in recent years. It will grow from $1.55 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing digitization of patient records, expansion of disease-specific research programs, growing regulatory reporting requirements, adoption of electronic health records, rising use of data-driven clinical decision tools.

The disease registry software market size is expected to see rapid growth in the next few years. It will grow to $2.64 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing demand for population health analytics, rising integration with AI-driven clinical insights, expansion of cloud-based registry deployments, growing focus on outcomes-based healthcare, increasing use of real-world data in clinical research. Major trends in the forecast period include increasing adoption of integrated disease registry platforms, rising use of cloud-based patient data management, growing focus on regulatory-compliant data reporting, expansion of ehr-integrated registry solutions, enhanced emphasis on real-world evidence collection.

The increasing adoption of personalized medicine is expected to drive the growth of the disease registry software market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic profile, lifestyle, and environment. This adoption is largely driven by advancements in genomics, which allow for precise identification of genetic variations and the development of tailored treatments. Disease registry software supports personalized medicine by systematically collecting and managing patient health data, enabling customized treatment plans and enhancing clinical decision-making. It streamlines access to and analysis of data, improving patient outcomes and advancing precision healthcare. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 approved in 2022. Consequently, the growing adoption of personalized medicine is driving the disease registry software market.

Key players in the disease registry software market are focusing on developing patient-centric registries that enable direct enrollment and longitudinal tracking to support personalized care. Digital registers are electronic systems or software platforms that systematically collect, store, and manage patient health information, replacing traditional paper-based registries. For instance, in August 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, launched the CONNECT-HCM Registry. This nationwide digital registry is designed to enhance the understanding and management of hypertrophic cardiomyopathy (HCM), the most common genetic cardiovascular disease. The registry allows direct patient enrollment beyond individual centers, addressing diagnostic and care gaps. It links registry data with electronic health records via Arboretum’s Hugo Connect platform, enabling researchers to track symptoms, imaging, treatments, and outcomes over time.

In November 2023, Health Catalyst Inc., a US-based healthcare analytics company, acquired Electronic Registry Systems Inc. (ERS) for an undisclosed amount. Through this acquisition, Health Catalyst aims to strengthen its oncology registry capabilities by integrating ERS’s cancer data management expertise into its tech-enabled managed services, enhancing data abstraction, reporting, and analytics for healthcare organizations. Electronic Registry Systems Inc. is a US-based company specializing in cancer registry software and services.

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University.

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disease registry software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the disease registry software market by increasing costs associated with imported servers, secure storage hardware, networking equipment, and compliance-oriented IT infrastructure. Hospitals, research centers, and government organizations in North America and Europe are most affected due to dependence on imported enterprise hardware, while Asia-Pacific faces higher costs in system deployment and upgrades. These tariffs are increasing total cost of ownership for registry platforms. However, they are also promoting cloud-first deployment models, local data hosting solutions, and increased investment in software-centric registry systems that reduce hardware reliance.

The disease registry software market research report is one of a series of new reports that provides disease registry software market statistics, including disease registry software industry global market size, regional shares, competitors with a disease registry software market share, detailed disease registry software market segments, market trends and opportunities, and any further data you may need to thrive in the disease registry software industry. This disease registry software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Disease registry software is a specialized digital platform designed to collect, organize, and manage patient data related to specific diseases or conditions. It enables healthcare providers, researchers, and policymakers to track disease patterns, monitor treatment outcomes, ensure regulatory compliance, and support clinical decision-making, ultimately improving patient care and population health.

The primary types of disease registry software are standalone and integrated. Standalone systems operate independently to collect, manage, and analyze disease-related patient data without relying on hospital or clinic systems. The databases may be public or commercial, with deployment options including on-premises and cloud-based solutions, and they serve end-users such as hospitals, government agencies, research centers, pharmaceutical companies, and others.

The disease registry software market includes revenues earned by entities through patient data management, real-time data collection, integration with electronic health records, analytics and reporting, clinical research support, chronic disease management, and public health surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.